Phio Pharmaceuticals (PHIO) Price to Book (2012 - 2026)

Phio Pharmaceuticals (PHIO) has reported Price to Book for 15 consecutive years, with 0.94 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 15.82% year-over-year to 0.94; the trailing twelve-month figure through Jun 2026 stood at 0.94 (down 15.82% YoY), and the FY2025 full-year result was 0.31, up 3.92% from the prior year.
• Price to Book improved to 0.94 in Q2 2026 per PHIO's latest filing, from 0.86 in the prior quarter.
• Across five years, Price to Book topped out at 1.46 in Q3 2025 and bottomed at 0.2 in Q4 2023.
• Historically, Price to Book has averaged 0.66 across 5 years, with a median of 0.58 in 2022.
• The sharpest annual moves came in 2023 and 2025: Price to Book tumbled 56.34% in 2023, then soared 118.15% in 2025.
• Over 5 years, Price to Book stood at 0.47 in 2022, then sank by 56.34% to 0.2 in 2023, then soared by 46.5% to 0.3 in 2024, then advanced by 3.92% to 0.31 in 2025, then soared by 201.5% to 0.94 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 0.94, 0.86, and 0.31 for Q2 2026, Q1 2026, and Q4 2025 respectively.